Table 3.
Mucosal Score (MS) from Baseline (B) Among the Intervention (I) and Control (C) Group to Three- and Six-Month Follow-Ups
| MS | B–3 Months | B–6 Months | 3–6 Months | |||
|---|---|---|---|---|---|---|
| p-value | 0.10 | 0.12 | 0.04* | |||
| I (n=70) | C (n=61) | I (n=69) | C (n=55) | I (n=69) | C (n=55) | |
| Deteriorated n (%) | 11 (15.71) | 4 (6.56) | 8 (11.59) | 1 (1.82) | 17 (24.64) | 6 (10.91) |
| Unchanged n (%) | 22 (31.43) | 29 (47.54) | 31 (44.93) | 28 (50.91) | 38 (55.07) | 42 (76.36) |
| Improved n (%) | 37 (52.86) | 28 (45.90) | 30 (43.48) | 26 (47.27) | 14 (20.29) | 7 (12.73) |
Notes: *p <0.05. All other comparisons, not significant.
Abbreviations: n, number of participants.